Slim Fortune capsules Dietary Supplement. Each bottle contains 30 capsules.
Published April 23, 2014 · Recall initiated: October 7, 2013
Summary
FDA records drug Class I recall D-1231-2014, published April 23, 2014 and initiated October 7, 2013. Recalling firm: B @ B Trade Inc.; Status: Terminated; Reported quantity: 10 bottles; Lot: ALL LOTS. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- B @ B Trade Inc.
- Distributor
- Nationwide
- Lot
- ALL LOTS
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASlim Expert softgel capsules Dietary Supplement. One month supply/ 30 softgels. 1 softgel - 650 mg.April 23, 2014
- FDALidiy capsules Dietary Supplement. Each bottle contains 30 capsules.April 23, 2014
- FDA1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.April 23, 2014
- FDAReusable latex breathing bags with multiple part numbers and sold as part of test lung part number andApril 16, 2014
- FDASit/stand Rolling Walker, SKU/Item Number 66838. Intended for use by those with difficulty walking andApril 16, 2014
- FDA400003 Medcare Lift with Scale 400013 Medcare Lift w/Scale 600 lb 400600 Scale Hanger Assembly Product Usage:April 16, 2014
Questions about this recall
Was Slim Fortune capsules Dietary Supplement. Each bottle contains 30 capsules. recalled?
Yes. FDA published recall D-1231-2014 on April 23, 2014. Reported hazard: Marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit